melarsoprol has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elstner, E; Koeffler, HP; Koshiuka, K; Said, JW; Tada, Y; Williamson, E | 1 |
1 other study(ies) available for melarsoprol and Prostatic Neoplasms
| Article | Year |
|---|---|
Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Division; Female; Humans; Male; Melarsoprol; Mice; Prostatic Neoplasms; Tretinoin; Trypanocidal Agents; Tumor Cells, Cultured | 2000 |